Astrazeneca

LUMOXITI

View Prices
  1. Home
    2.  / 
  2. J Code
    3.  / LUMOXITI – J9313

Manufacturer:

Astrazeneca

Name:

LUMOXITI

HCPCS Code Descriptor:

Injection, moxetumomab pasudotox-tdfk, 0.01 mg

Category:

J Code

HCPCS:

J9313

NDC(s):

00310-4700-01

Primary Type:

Oncology

Generic Status:

Single-Source

Route of Administration:

Intravenous

About:

LUMOXITI is an Oncology drug manufactured by Astrazeneca and administered via the Intravenous route of administration. The J Code: J9313 is aligned to the drug LUMOXITI.

View Prices

Access Pricing and More By Registering

Register Now

HCPCS Added Date:

10/1/19

HCPCS Effective Date:

10/1/19

HCPCS Short Description:

Inj., lumoxiti, 0.01 mg

Billing and Coding Guide:

https://www.myaccess360.com/content/dam/website-services/us/552-access360/hcp-pdf/LUMOXITI-Coding-Resource.pdf

Patient Assistance:

https://www.myaccess360.com/home.html

LUMOXITI - J9313